Sun Pharma To Purchase US-listed Organon In A Nearly $11.8 billion Deal

Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India’s biggest outbound deals.The acquisition would help Sun Pharma further expand its women’s health portfolio with access to

Read More

  • Related Posts

    RBI Scraps Paytm Payments Bank Licence; Is Your Money Safe? Here is a Step-by-Step Refund Guide

    The RBI has revoked PPBL’s licence under Section 22(4) of the Banking Regulation Act, 1949. While the bank is now prohibited from conducting any banking business, both the RBI and Paytm have confirmed that the bank possesses sufficient liquidity to repay all depositors. Users wit Read More

    Markets Convinced On US-Iran War Outcome: Stock Market Expert Sunil Shah After Sensex Surges Over 700 Pts

    In the backdrop of benchmark stock market index Sensex rallying over 700 points or nearly 1%, stock market expert Sunil Shah said D-street is getting convinced regarding the outcome of the West Asia current crisis and how diplomacy will play a major role rather than armed forces. Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *